Shesa's Investment Blog

Amarin Corporation (AMRN) Amarin stock has rocketed almost 40% in last 3-4 trading days and currently trading at $24.02 . I had sent many message to my WhatsApp group about its potential and also wrote on my blog many times. But let's take a quick look on the latest news. On Thursday, 11/15. there was AdCom meeting where the  panel voted 16-0 in favor of expanding approval of its cardiovascular drug Vascepa , potentially opening up a multi-billion dollar opportunity in the market. This is not final FDA approval but a great news for Amarin shareholders. It's highly likely that FDA should approve the drug when it is unanimously voted by the panel.  As I have said before, there are many catalyst for this company which has enormous potential. I am listing few of those for readers information. On Monday, they will publish the data for their Evaporate study which should strengthen their position further. We will know in a couple of days. Approval of Vascepa in Cana...

November 10, 2019 NOVEMBER 2019 - INVESTMENT BLOG By Shesa Nayak U.S. Stock Market Update   The stock market stormy season seems to have gone! November has started with a bang.    All major stock indexes DOW, NASDAQ and S&P 500 have hit their all-time high in last few days. Interestingly, U.S stock market momentum is pushing all other world stock market indexes for positive return despite their lackluster economy. Meanwhile, third quarter earnings season is underway and 71% of the companies have already reported their earnings. The notable good earnings came from some of the big technology powerhouse like Apple, Microsoft, Facebook, Intel and Alibaba. Overall, earnings from corporate America have been much better than expected. The Federal reserve further reduced 0.25% interest rate on the last FOMC meeting on October 30. This was third consecutive interest rate cut by Federal Reserve this year. Last Friday, president Trump said that U.S and China ...